Status:
COMPLETED
Florbetaben PET Imaging in PPA
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Northwestern University
Conditions:
Primary Progressive Aphasia
Alzheimer Disease
Eligibility:
All Genders
18-100 years
Brief Summary
The purpose of this research is to better understand how dementia affects activity in different parts of the brain.
Detailed Description
This study will examine Positron Emission Tomography (PET) imaging with Florbetaben F18. Florbetaben F18 is a radioactive tracer that binds to particles in your brain. This process displays activity i...
Eligibility Criteria
Inclusion
- Participants must have a diagnosis of PPA or a related dementia syndrome
Exclusion
- Pregnant
- Breastfeeding
- Receiving radiation clinically
Key Trial Info
Start Date :
August 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 26 2021
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04720001
Start Date
August 23 2018
End Date
February 26 2021
Last Update
October 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago - American School Building
Chicago, Illinois, United States, 60637